tm logo
DENPHARMA
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 18 Mar 2024

Last Applicant/ Owned by

3010 LBJ Freeway, Suit 1200

Dallas

TX

75234

Serial Number

90831702 filed on 15th Jul 2021

Registration Number

N/A

Correspondent Address

Michael Markos

LEGALFORCE RAPC WORLDWIDE, P.C.

446 E SOUTHERN AVE

TEMPE,AZ 85282

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

DENPHARMA

Pharmaceutical preparations for the treatment of opioid dependence; antibacterials, namely, antibacterial cleaners, antibacterial hand lotions, and antibacterial pharmaceuticals; pharmaceutical agents for the treatment of respiratory ailments, prevention of endometrial hyperplasia and secondary amenorrhea; anti-viral disinfectants; anti-infectives; vitamins; dietary and nutritional supplements; anRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of opioid dependence; antibacterials, namely, antibacterial cleaners, antibacterial hand lotions, and antibacterial pharmaceuticals; pharmaceutical agents for the treatment of respiratory ailments, prevention of endometrial hyperplasia and secondary amenorrhea; anti-viral disinfectants; anti-infectives; vitamins; dietary and nutritional supplements; antacids; Pharmaceutical products and preparations, namely, inhalant anesthetics, injectable contraceptives, nasal spray preparations; topical anesthetic prepared as a sterile aqueous ophthalmic solution; ocular anesthetics; ophthalmic solutions for the treatment of elevated intraocular pressure in individuals with ocular hypertension or open angle glaucoma; hypnotic sedative anesthetic compounds; ophthalmic pharmaceuticals, namely, mydriatics; pharmaceutical preparations for the treatment of respiratory conditions; oral analgesics; oral analgesics in solution or liquid form; analgesic preparations; spinal anesthetics; anti-diarrheal agents; prescription synthetic narcotics; anxiolytics; anti-seizure medications; topical anesthetics; pharmaceutical preparations for treatment of arsenic, gold and mercury poisoning and acute lead poisoning; pharmaceutical preparations for relief of nasal congestion, sinus pressure and sinus headaches; nasal spray preparations; topical preparations for the treatment of arthritis, joint pain, back pain, foot pain and muscle pain; preparations for the relief of pain; pain relief medications; magnesium supplements; preparations for the relief of arthritis and joint pain; cough suppressants and expectorants; cough drops and syrups; preparations for treating symptoms of common colds and influenza; medicated foot creams; skin care lotions and skin care ointments; medicated skin creams and lotions, namely, anti-itch creams; medicated tinctures and ointments for lip and skin care; eye drops; lubricant eye drops; contact lens wetting solutions; veterinary pain relief medications, namely, topical anesthetics and sedatives; veterinary medical eye wash; pharmaceutical products and preparations for fertility, namely, fertility enhancement preparations, and birth control, namely contraceptive preparations; pharmaceutical products and preparations for treating wounds and poisoning; pharmaceuticals and pharmaceutical preparations, namely, antibacterial pharmaceuticals for protection against bacterial agents resistant to antibiotics; pharmaceutical products and preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical products and preparations for the treatment of respiratory conditions; analgesic preparations; pharmaceutical products and preparations for the prevention and treatment of infectious parasitic diseases, neoplasms, diseases of blood or blood-forming organs or disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases and disorders; pharmaceutical products and preparations for the prevention and treatment of mental and behavioral disorders in the nature of diseases of the nervous system, neurological diseases and disorders, and neurodegenerative diseases and disorders

Mark Details


Serial Number

No 90831702

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2007121

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.15.11 -

Bubbles, foamy masses

26.03.21 -

Ovals that are completely or partially shaded

Description of Design Search

The mark consists of the stylized wording "Denpharma" within a shaded oval; a stylized bubble appears above the letter "n".

Legal History


Show more

Status DateAction Taken
18th Mar 2024ABANDONMENT - NO USE STATEMENT FILED
18th Mar 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
05th Aug 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03rd Aug 2023SOU TEAS EXTENSION RECEIVED
03rd Aug 2023SOU EXTENSION 1 FILED
03rd Aug 2023SOU EXTENSION 1 GRANTED
14th Feb 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01st Jan 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
22nd Sep 2022EXTENSION OF TIME TO OPPOSE RECEIVED
23rd Aug 2022PUBLISHED FOR OPPOSITION